Difference between revisions of "Team:Yale/collaborations"
Colin.hemez (Talk | contribs) |
Colin.hemez (Talk | contribs) |
||
| Line 58: | Line 58: | ||
<h2 id="overview">Collaborations</h2> | <h2 id="overview">Collaborations</h2> | ||
<h3>Featuring University of La Verne!</h3> | <h3>Featuring University of La Verne!</h3> | ||
| − | <div class="page__button"><a href="#guidebook" class="custom__button">Guidebook | + | <div class="page__button"><a href="#guidebook" class="custom__button">Guidebook</a> |
</div> | </div> | ||
</section> | </section> | ||
<section class="content__section__alt"> | <section class="content__section__alt"> | ||
| − | <h2 id="guidebook">Developing a Guidebook - <a href=" | + | <h2 id="guidebook">Developing a Guidebook - <a href="https://2015.igem.org/Team:LaVerne-Leos" target="https://2015.igem.org/Team:LaVerne-Leos" class="uni__link">University of La Verne iGEM</a></h2> |
<h3>Beginning Research in Non-Model Microbes</h3> | <h3>Beginning Research in Non-Model Microbes</h3> | ||
<p>Over the past few years, iGEM has increasingly centered around non-model microorganisms—organisms which are less well-characterized and have fewer resources for genetic manipulation than the model E. coli and S. cerevisiae. Despite a prevalence of non-model organisms in iGEM competition projects and the potential impact which these projects may have, few resources exist for teams hoping to initiate research in non-model strains.</p> | <p>Over the past few years, iGEM has increasingly centered around non-model microorganisms—organisms which are less well-characterized and have fewer resources for genetic manipulation than the model E. coli and S. cerevisiae. Despite a prevalence of non-model organisms in iGEM competition projects and the potential impact which these projects may have, few resources exist for teams hoping to initiate research in non-model strains.</p> | ||
Revision as of 03:11, 17 September 2015
<!DOCTYPE html>
Collaborations
Featuring University of La Verne!
Developing a Guidebook - University of La Verne iGEM
Beginning Research in Non-Model Microbes
Over the past few years, iGEM has increasingly centered around non-model microorganisms—organisms which are less well-characterized and have fewer resources for genetic manipulation than the model E. coli and S. cerevisiae. Despite a prevalence of non-model organisms in iGEM competition projects and the potential impact which these projects may have, few resources exist for teams hoping to initiate research in non-model strains.
The 2015 Yale University iGEM team has collaborated with several other teams working in non-model strains to design a set of considerations for future iGEM teams in order to reduce the barrier to entry into non-model organisms. We synthesized the experiences of other teams into a handout, which has been made available on our team wiki and will be available at out poster at the Jamboree.
ProtoCat - University of Michigan
A Centralized, Validated Protocols Database
Biofilm formation on surfaces is an issue in the medical field, naval industry, and other areas. We developed an anti-fouling peptide with two modular components: a mussel adhesion protein (MAP) anchor and LL-37, an antimicrobial peptide. MAPs can selectively attach to metal and organic surfaces via L-3,5-dihydroxyphenylalanine (L-DOPA), a nonstandard amino acid that was incorporated using a genetically recoded organism (GRO). Because this peptide is toxic to the GRO in which it is produced, we designed a better controlled inducible system that limits basal expression. This was achieved through a novel T7 riboregulation system that controls expression at both the transcriptional and translational levels.
Biofilm formation on surfaces is an issue in the medical field, naval industry, and other areas. We developed an anti-fouling peptide with two modular components: a mussel adhesion protein (MAP) anchor and LL-37, an antimicrobial peptide. MAPs can selectively attach to metal and organic surfaces via L-3,5-dihydroxyphenylalanine (L-DOPA), a nonstandard amino acid that was incorporated using a genetically recoded organism (GRO). Because this peptide is toxic to the GRO in which it is produced, we designed a better controlled inducible system that limits basal expression. This was achieved through a novel T7 riboregulation system that controls expression at both the transcriptional and translational levels.
Yale iGEM 2015
Main Campus:
Yale Department of Molecular, Cellular & Developmental Biology
Attn: Farren Isaacs/iGEM
219 Prospect St
PO Box 208103
New Haven, CT 06520
Tel. +1(203) 432-3783
E-mail: igem.yale@gmail.com
© Yale iGEM 2015